EIA recommendations for the 77th Meeting of the CITES Standing Committee
Learn more about focal issues that EIA’s Wildlife Campaign aims to discuss during SC77.
Learn more about focal issues that EIA’s Wildlife Campaign aims to discuss during SC77.
EIA’s research, conducted over the past two years, reveals the continued online availability of at least 88 traditional Chinese medicine (TCM) products stated to contain leopard, pangolin and, in a few cases, tiger and rhino, manufactured by 72 Chinese companies which have been licensed by the National Medical Products Administration of China.
This comprehensive toolkit brings together in one place a range of measures and resources that governments of tiger range countries can use to counter trafficking of tigers, their parts and derivatives – including from farmed tigers.
Parties to the 19th meeting of the Conference of the Parties (CoP19) are reminded of the critical conservation status of Asia’s big cats
The 19th meeting of the Conference of the Parties (CoP19) to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) will take place from 14-25 November in Panama City. EIA encourages CITES Parties and stakeholders to consider information contained in this document when making decisions on proposals and matters in […]
Ahead of the 74th Meeting of the Standing Committee of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), EIA has prepared comments and recommendations on agenda items relating to Elephants, Pangolins, Tigers and other Asian Big Cats, Rhinos, Totoaba, Saiga, enforcement and compliance matters.